Recent research focusing on Semaglutide at a dosage of 40mg is shedding new light on its potential benefits. Initial findings suggest that this higher dosage may boost the drug's ability to manage blood glucose, potentially offering improved outcomes for individuals with insulin resistance. Further research is underway to fully understand the long-… Read More